If a global launch strategy is built on a billion dollars of R&D, why do we leave the last mile of communication up to chance?
As Pharmaceutical Executive highlighted, the Mechanism of Action (MoA) is the heart of a brand’s story. Yet, it remains the single most difficult narrative for field teams to execute. In an environment where clinicians are time-poor, data-overloaded, and skeptical of marketing gloss, the MoA is your sharpest hook.
It is how you differentiate. It is how you justify the switch. It is how you turn a molecule into a patient benefit.
However, brands that fail to control the MoA narrative early risk stalling adoption of existing drugs and the sale of other drugs.The problem isn’t the science; it’s the transfer of capability.
What is the mechanism of action (MoA)?
In pharmacology, the mechanism of action (MoA) is the specific biochemical interaction through which a drug substance produces its pharmacological effect. In simple terms, it refers to how a drug works inside the body to produce its effect.
This typically involves the drug binding to a specific molecular target, such as an enzyme or receptor, to exert its therapeutic effect. The mechanism of action explains how a drug works at the molecular or cellular level to bring about its intended effect in the body.
The Gap Between Training and Execution
After reading that definition, consider what is being asked of pharmaceutical sales representatives: take the complex molecular science of a pharmaceutical drug and render it rigorous, relatable, and compliant, and tailor it instantly to a specific doctor’s personality and business.
Traditionally, pharmaceutical training, training courses and sales development include:
- A slide deck.
- A didactic workshop.
- A brief role-play with a colleague (who is usually too nice to give real feedback).
Then, sales reps are sent into high-stakes conversations with clinicians who are already skeptical of the drug development information. This “trial by fire” approach leads to messaging drift. The story gets muddled, overly technical, or dangerously inconsistent.
Medical professionals demand clarity. Patients deserve accuracy. Pharmaceutical companies require consistency in sales.
Virti’s Approach: Bridging the Gap with AI Simulation
At Virti, we don’t believe in learning by listening; we believe in learning by doing. We have built an artificial intelligence platform that replaces passive training courses and builds on course content with safe, repeatable, active practice.
Here is how we are operationalizing MOA in the pharmaceutical industry:
1. Precision practice with Virtual Humans (AI Avatars)
Sales reps engage in voice-based simulations with virtual healthcare professionals (HCPs). These personas vary in personality and scientific acumen. One might be a data-driven skeptic; another might be an impatient “bottom-line” clinician. This forces the rep to adapt the MOA narrative in real-time, mirroring the unpredictability of the field.
2. Objective, compliance-focused feedback
Subjective feedback (“You did great!”) doesn’t drive behavior change. Our platform uses machine learning and acts as an impartial coach, providing immediate data on:
- Scientific Accuracy: Did they explain the mechanism correctly?
- Message Adherence: Did they use the approved analogies of the company’s products or drift off-script?
- Soft Skills: Analysis of tone, pacing, and empathy.
3. Risk visibility for leadership
For Commercial and Medical heads, this eliminates the guessing game. Virti dashboards provide a clear view of field readiness, highlighting:
- Who is ready to launch.
- Where the compliance risks lie.
- Which specific parts of the MOA narrative are confusing the field force.
The Real-Life Impact
When teams move from passive learning to active simulation, the metrics change. We recently supported a large field team launching a product with a novel mechanism, developed through extensive pharmaceutical research. Following simulation-based practice, the results were distinct:
- Accelerated Ramp-Up: New hires hit competency milestones 40–60% faster.
- Message Integrity: Medical Affairs noted a significant reduction in messaging drift.
- Higher Engagement: Senior reps reported growth in knowledge base, higher confidence handling objections, leading to increased HCP engagement scores.
Why This Matters
I lead Virti because I believe that human performance is the variable that changes outcomes.
When a pharmaceutical sales representative steps into a simulation, struggles, adjusts, and tries again, they are building the neural pathways required for high-pressure performance. They make their mistakes with an avatar, so they don’t make them with a Key Opinion Leader.
Better training leads to clearer communication. Clearer communication leads to informed prescribing decisions. And that, ultimately, is how we serve the patient.
Is your team ready to tell the story? Whether you are approaching a launch, refreshing a legacy brand, or onboarding new talent, we can help you deploy confident, scientifically grounded storytellers at scale.
by Kurt Kratchman, CEO at Virti – Let’s connect